Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2.

Santos AS, de Araújo LP, Orts DJB, da Costa HHM, Matteucci KC, Silva EN, Oliveira KC, Galdino G, Prudencio CR, Corsetti PP, de Almeida LA

Open source

DOI: 10.3389/fimmu.2026.1775087
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1775087,
  title = {Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2.},
  author = {Santos AS and de Araújo LP and Orts DJB and da Costa HHM and Matteucci KC and Silva EN and Oliveira KC and Galdino G and Prudencio CR and Corsetti PP and de Almeida LA},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1775087},
  url = {https://doi.org/10.3389/fimmu.2026.1775087}
}

RIS

TY  - JOUR
TI  - Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2.
AU  - Santos AS
AU  - de Araújo LP
AU  - Orts DJB
AU  - da Costa HHM
AU  - Matteucci KC
AU  - Silva EN
AU  - Oliveira KC
AU  - Galdino G
AU  - Prudencio CR
AU  - Corsetti PP
AU  - de Almeida LA
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1775087
UR  - https://doi.org/10.3389/fimmu.2026.1775087
ER  -

APA

AS, S., LP, D. A., DJB, O., HHM, D. C., KC, M., EN, S., KC, O., G, G., CR, P., PP, C., & LA, D. A. (2026). Bacillus Calmette-Guérin as adjuvant platform enhances immunogenicity of conserved epitopes from structural proteins of SARS-CoV-2.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1775087

Source records

pubmed · retrieved 2026-09-27T07:03:53.416Z